Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Insight Partners | PRODUCT CODE: 1206520

Cover Image

PUBLISHER: The Insight Partners | PRODUCT CODE: 1206520

Asia Pacific Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type ; Route of Administration ; End User

PUBLISHED:
PAGES: 183 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF (Single User License)
USD 3000
PDF (Site License)
USD 4000
PDF (Enterprise License)
USD 5000

Add to Cart

The APAC malaria treatment market is expected to grow from US$ 235.63 million in 2022 to US$ 347.39 million by 2028. It is estimated to register a CAGR of 6.7% from 2022 to 2028.

Initiatives by Government and Private Sectors to Raise Awareness About Malaria is Fueling the APAC Malaria Treatment Market

Malaria awareness campaigns help enhance knowledge regarding the disease, improve behaviors promoting health, and promote intersectoral collaboration and social support. The WHO coordinates the Global Malaria Programme (GMP) as part of its efforts to control and eradicate malaria. The program is led by the "Global Technical Strategy for Malaria 2016-2030" adopted by the World Health Assembly in May 2015, which was further restructured in 2021. The WHO observes 25 April as World Malaria Day every year to highlight the collective energy and commitment of the malaria communities in uniting around the common objective of freeing from malaria. In 2016, India introduced its first National Framework for Malaria Elimination, which will be valid from 2016 through 2030. In 2019, the Indian government raised funding by more than 25% for the National Vector Borne Disease Control Programme, launched in 2003. The country has also increased its contribution as a donor to the Global Fund to fight Malaria. Several governments are taking initiatives to create awareness and conduct research to develop new antimalarial drugs and vaccines. Private companies are also engaging in the fight against malaria and investing heavily in R&D activities. Governments in countries with a high malaria prevalence are deploying various strategies to eradicate malaria by improving access to treatment and helping communities in malaria-endemic countries deliver better healthcare. Several initiatives by governments and private companies to spread awareness about malaria and reinforce malaria eradication efforts are bolstering the APAC malaria treatment market growth.

APAC Malaria Treatment Market Overview

The APAC malaria treatment market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. China dominated the market in 2022. According to the World Health Organization (WHO) 2021 report, China is awarded a malaria-free certification. China has achieved a 99% drop in malaria cases from 30 million to 30,000 cases annually. This is achieved by providing a basic public health service package for its residents without charging fees. From these packages, all people in China have access to affordable services for the diagnosis and treatment of malaria, regardless of legal or financial status. Additionally, multi-sector collaboration in China also played a big part in achieving zero cases in China. For example, 13 ministries in China-health, education, finance, research and science, development, public security, the army, police, commerce, industry, information technology, customs, media, and tourism-joined forces to end malaria. Further, through the support from the Global Fund to fight AIDS, tuberculosis, and malaria, China had stepped up training, laboratory equipment, staffing, and mosquito control measures that were required to find, treat, and prevent malaria cases in China, which, in turn, boosted the growth of the APAC malaria treatment market in the country.

Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

APAC Malaria Treatment Market Segmentation

The APAC malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the APAC malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the APAC malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the APAC malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the APAC malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the APAC malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The hospitals segment held the largest market share in 2022.

Based on country, the APAC malaria treatment market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. Our regional analysis states that China dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, VLP Therapeutics LLC, and Zydus Healthcare Ltd are among the leading companies operating in the APAC malaria treatment market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC malaria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the malaria treatment market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Product Code: TIPRE00025037

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 APAC Malaria Treatment Market - By Treatment
    • 1.3.2 APAC Malaria Treatment Market - By Drug Type
    • 1.3.3 APAC Malaria Treatment Market - By Route of Administration
    • 1.3.4 APAC Malaria Treatment Market - By Distribution Channel
    • 1.3.5 APAC Malaria Treatment Market - By End User
    • 1.3.6 APAC Malaria Treatment Market- By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. APAC Malaria Treatment Market- Market Landscape

  • 4.1 Overview
  • 4.2 APAC PEST Analysis
  • 4.3 Experts Opinion

5. APAC Malaria Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Malaria
    • 5.1.2 Government and Private Sector's Initiatives to Raise Awareness About Malaria
  • 5.2 Market Restraints
    • 5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
  • 5.3 Market Opportunities
    • 5.3.1 Extending Pipeline of New Drugs and Vaccines
  • 5.4 Future Trends
    • 5.4.1 Rapid Diagnostic Tests
  • 5.5 Impact Analysis

6. Malaria Treatment Market- APAC Analysis

  • 6.1 APAC Malaria Treatment Market Revenue Forecast and Analysis

7. APAC Malaria Treatment Market Analysis - By Treatment

  • 7.1 Overview
  • 7.2 APAC Malaria Treatment Market, By Treatment 2021 & 2028 (%)
  • 7.3 Prescription Medications
    • 7.3.1 Overview
    • 7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.3 Chloroquine Phosphate
      • 7.3.3.1 Overview
      • 7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.4 Artemisinin- based Combination Therapies (ACTs)
      • 7.3.4.1 Overview
      • 7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.5 Atovaquone-Proguanil
      • 7.3.5.1 Overview
      • 7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
      • 7.3.6.1 Overview
      • 7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.7 Primaquine Phosphate
      • 7.3.7.1 Overview
      • 7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.8 Others
      • 7.3.8.1 Overview
      • 7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Vaccines
    • 7.4.1 Overview
    • 7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5 Diagnostic Tests
    • 7.5.1 Overview
    • 7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. APAC Malaria Treatment Market Analysis - By Drug Type

  • 8.1 Overview
  • 8.2 APAC Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
  • 8.3 Branded
    • 8.3.1 Overview
    • 8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Generics
    • 8.4.1 Overview
    • 8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)

9. APAC Malaria Treatment Market Analysis - By Route of Administration

  • 9.1 Overview
  • 9.2 APAC Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
  • 9.3 Oral
    • 9.3.1 Overview
    • 9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Parenteral and Intravenous Mode
    • 9.4.1 Overview
    • 9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)

10. APAC Malaria Treatment Market Analysis - By Distribution Channel

  • 10.1 Overview
  • 10.2 APAC Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
  • 10.3 Direct Tender
    • 10.3.1 Overview
    • 10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.4 Hospital Pharmacies
    • 10.4.1 Overview
    • 10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.5 Retail Pharmacies
    • 10.5.1 Overview
    • 10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.6 Online Pharmacies
    • 10.6.1 Overview
    • 10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.7 Others
    • 10.7.1 Overview
    • 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. APAC Malaria Treatment Market Analysis - By End User

  • 11.1 Overview
  • 11.2 APAC Malaria Treatment Market, By End User 2021 & 2028 (%)
  • 11.3 Hospitals
    • 11.3.1 Overview
    • 11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.4 Specialty Clinics
    • 11.4.1 Overview
    • 11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.5 Homecare
    • 11.5.1 Overview
    • 11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.6 Others
    • 11.6.1 Overview
    • 11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. APAC Malaria Treatment Market - Country Analysis

  • 12.1 Overview
    • 12.1.2 APAC: Malaria Treatment Market, by Country, 2021 & 2028 (%)
      • 12.1.2.1 Japan: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.1.1 Overview
        • 12.1.2.1.2 Japan: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.1.3 Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
        • 12.1.2.1.3.1 Japan: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.1.4 Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
        • 12.1.2.1.5 Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.1.2.1.6 Japan: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.1.7 Japan: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.2 China: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.2.1 Overview
        • 12.1.2.2.2 China: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.2.3 China: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
        • 12.1.2.2.3.1 China: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.2.4 China: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
        • 12.1.2.2.5 China: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.1.2.2.6 China: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.2.7 China: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.3 India Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.3.1 Overview
        • 12.1.2.3.2 India: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.3.3 India: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
        • 12.1.2.3.3.1 India: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.3.4 India: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
        • 12.1.2.3.5 India: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.1.2.3.6 India: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.3.7 India: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.4 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.4.1 Overview
        • 12.1.2.4.2 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.4.3 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
        • 12.1.2.4.3.1 South Korea: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.4.4 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
        • 12.1.2.4.5 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.1.2.4.6 South Korea: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.4.7 South Korea: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.5 Australia: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.5.1 Overview
        • 12.1.2.5.2 Australia: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.2.5.3 Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
        • 12.1.2.5.3.1 Australia: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.5.4 Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
        • 12.1.2.5.5 Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.1.2.5.6 Australia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.5.7 Australia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.6 Rest of APAC: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.1 Overview
        • 12.1.2.6.2 Rest of APAC: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.3 Rest of APAC: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
        • 12.1.2.6.3.1 Rest of APAC: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.6.4 Rest of APAC: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
        • 12.1.2.6.5 Rest of APAC: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.1.2.6.6 Rest of APAC: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.7 Rest of APAC: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Inorganic Growth Strategies
    • 13.2.1 Overview
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview

14. Company Profiles

  • 14.1 Zydus Healthcare Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sun Pharmaceutical Industries Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Sanofi SA
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 GSK Plc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Novartis AG
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Cipla Ltd
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Viatris Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Lupin Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 AdvaCare Pharma USA LLC
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 VLP Therapeutics LLC
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms
Product Code: TIPRE00025037

List Of Tables

  • Table 1. APAC Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
  • Table 3. Japan: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
  • Table 5. Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 6. Japan: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. China: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
  • Table 9. China: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. China: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
  • Table 11. China: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 12. China: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. China: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. India: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
  • Table 15. India: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. India: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
  • Table 17. India: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 18. India: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. India: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
  • Table 21. South Korea: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
  • Table 23. South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 24. South Korea: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. South Korea: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
  • Table 27. Australia: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
  • Table 29. Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 30. Australia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Australia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of APAC: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
  • Table 33. Rest of APAC: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Rest of APAC: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)
  • Table 35. Rest of APAC: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 36. Rest of APAC: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Rest of APAC: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Recent Inorganic Growth Strategies
  • Table 39. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 40. Glossary of Terms

List Of Figures

  • Figure 1. APAC Malaria Treatment Market Segmentation
  • Figure 2. APAC Malaria Treatment Market Segmentation, By Country
  • Figure 3. APAC Malaria Treatment Market Overview
  • Figure 4. APAC Malaria Treatment Market, By Distribution Channel
  • Figure 5. APAC Malaria Treatment Market, By Country
  • Figure 6. APAC PEST Analysis
  • Figure 7. APAC Malaria Treatment Market impact analysis of driver and restraints
  • Figure 8. APAC Malaria Treatment Market - Revenue Forecast and Analysis
  • Figure 9. APAC Malaria Treatment Market, by Treatment 2021 & 2028 (%)
  • Figure 10. Prescription Medication: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Chloroquine Phosphate: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 12. Artemisinin- based Combination Therapies (ACTs): APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 13. Atovaquone-Proguanil: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 15. Primaquine Phosphate: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 16. Others: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 17. Vaccines: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 18. Diagnostic Tests: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 19. Others: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. APAC Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
  • Figure 21. Branded: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 22. Generics: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. APAC Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
  • Figure 24. Oral: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Parenteral and Intravenous Mode: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. APAC Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
  • Figure 27. Direct Tender: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 28. Hospital Pharmacies: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Retail Pharmacies: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. Online Pharmacies: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 31. Others: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. APAC Malaria Treatment Market, by End User 2021 & 2028 (%)
  • Figure 33. Hospitals: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 34. Specialty Clinics: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 35. Homecare: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. Others: APAC Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 37. APAC Malaria Treatment Market Overview, by Country (2021)
  • Figure 38. APAC: Malaria Treatment Market, by Country, 2021& 2028 (%)
  • Figure 39. Japan: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 40. China: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 41. India: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 42. South Korea: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 43. Australia: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 44. Rest of APAC: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!